日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia

KAT6/KAT7 的催化抑制可增强 MLL 白血病中 Menin 抑制剂的疗效并克服其原发性和获得性耐药性。

Shellaina J V Gordon ,Florian Perner ,Laura MacPherson ,Katie A Fennell ,Daniela V Wenge ,Wallace Bourgeois ,Tabea Klaus ,Thomas Plenge ,Anelya Murat ,Jelena Petrovic ,Jakub Horvath ,Joan Q Cao ,John D Lapek Jr ,Sean Uryu ,Jeffrey R White ,Enid Y N Lam ,Xinmeng Jasmine Mu ,Yih-Chih Chan ,Andrea Gillespie ,Benjamin J Blyth ,Michelle A Camerino ,Ylva E Bozikis ,Henrietta Holze ,Kathy Knezevic ,Jesse Balic ,Paul A Stupple ,Ian P Street ,Brendon J Monahan ,Shikhar Sharma ,Elanor N Wainwright ,Dane Vassiliadis ,Thomas A Paul ,Scott A Armstrong ,Mark A Dawson

Fluorinated pyrimidine 5-carboxamides as potential tools for MERTK targeted fluorine-18-PET-radioligand development

氟化嘧啶5-甲酰胺作为MERTK靶向氟-18-PET放射性配体开发的潜在工具

Mudududdla, Ramesh; Wong, Siu Wai; Nguyen, Nghi; Xue, Lian; Stashko, Michael A; Wang, Xiaodong; Vivash, Lucy; Binder, Michele D; Ackermann, Uwe; Bozikis, Ylva E; Kilpatrick, Trevor J; Baell, Jonathan B

Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders

美国静脉血栓栓塞症绩效评估:一个涉及众多利益相关者的不断发展的格局

Braun, Barbara I; Kolbusz, Karen M; Bozikis, Michele R; Schmaltz, Stephen P; Abe, Karon; Reyes, Nimia L; Dardis, Michelle N

Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK α2β2γ1 by the Glucose Importagog SC4

葡萄糖导入因子 SC4 激活骨骼肌 AMPK α2β2γ1 的小分子结构决定因素

Kevin R W Ngoei, Christopher G Langendorf, Naomi X Y Ling, Ashfaqul Hoque, Swapna Varghese, Michelle A Camerino, Scott R Walker, Ylva E Bozikis, Toby A Dite, Ashley J Ovens, William J Smiles, Roxane Jacobs, He Huang, Michael W Parker, John W Scott, Mark H Rider, Richard C Foitzik, Bruce E Kemp, Jona